Intuitive Surgical, Inc.

ISRG

Market Cap$177.75B

Volume1.87M

Revenue$9.14B

Gross Profits$6.09B

Employees15638

EquityMedical Instruments & SuppliesHealthcareUSDwww.intuitive.com

About

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da ...

AI Summary

Model	Near-Term (0-3 mo.)	Mid-Term (3-12 mo.)	Long-Term (1-5 yr.)
Deepseek	Hold	Buy	Strong Buy
OpenAI	Hold	Buy	Strong Buy
Gemini	Hold	Hold	Buy
Grok	Hold	Buy	Strong Buy

Detailed Analysis

Deepseek

Holdnear term

Current price is below the fifty-day average, indicating potential short-term volatility.

Valuation:High forward PE suggests overvaluation in the near term.

Technical:Price below fifty-day average may indicate short-term bearish sentiment.

Sentiment:Market sentiment is mixed with high beta indicating volatility.

News:No significant recent news to drastically impact near-term price.

Buymid term

Potential for recovery towards the two-hundred-day average as market stabilizes.

Valuation:Trailing PEG ratio suggests growth may justify current valuations over time.

Technical:Approach towards two-hundred-day average could signal buying opportunity.

Sentiment:Long-term growth prospects in healthcare may improve sentiment.

News:Innovation in medical technology could drive positive news flow.

Strong Buylong term

Strong sector growth and innovation leadership support long-term appreciation.

Valuation:Market cap and sector position support long-term growth potential.

Technical:Historical performance indicates resilience and growth over longer periods.

Sentiment:Positive long-term outlook for healthcare and technology integration.

News:Continued leadership in robotic surgery expected to drive growth.

Gemini

Holdnear term

Short-term price may fluctuate around averages; hold for stability.

Valuation:High forward P/E suggests overvaluation.

Technical:Price below 50-day average, near 200-day average.

Sentiment:Neutral sentiment due to mixed technical signals.

News:Monitor upcoming earnings reports for catalysts.

Holdmid term

Growth potential exists, but high valuation warrants caution; hold position.

Valuation:High PEG ratio indicates potential overvaluation.

Technical:Monitor for breakout above 50 and 200-day averages.

Sentiment:Market sentiment may shift with earnings reports.

News:Track new product launches and market expansion.

Buylong term

Long-term growth potential in robotic surgery justifies investment.

Valuation:Long-term growth may justify current valuation.

Technical:Expect volatility due to high beta.

Sentiment:Positive long-term outlook for healthcare sector.

News:Focus on innovation and market leadership.

Openai

Holdnear term

Current price near average levels suggests a stable outlook short-term.

Valuation:High forward PE and PEG ratios indicate premium pricing.

Technical:Price close to both 50-day and 200-day averages.

Sentiment:Neutral market sentiment in the short term.

News:No significant recent news impacting immediate price.

Buymid term

Potential for growth as sector innovations continue.

Valuation:Premium valuation, but justified by growth prospects.

Technical:Stable technical indicators with potential for breakout.

Sentiment:Growing positive sentiment due to sector advancements.

News:Ongoing developments in healthcare technology may boost performance.

Strong Buylong term

Long-term growth expected from sustained technological leadership.

Valuation:High valuation reflects strong future earnings potential.

Technical:Long-term trends suggest upward trajectory.

Sentiment:Strong positive sentiment on long-term innovation impact.

News:Continued leadership in healthcare innovation supports growth.

Grok

Holdnear term

Current price below moving averages suggests caution. Momentum may stabilize soon.

Valuation:High forward P/E at 66.93 indicates overvaluation risk.

Technical:Price below 50-day and 200-day averages signals bearishness.

Sentiment:Market sentiment appears neutral with limited catalysts.

News:No significant recent news impacting near-term outlook.

Buymid term

Potential recovery as healthcare sector gains traction. High beta suggests volatility.

Valuation:Trailing PEG ratio of 3.73 shows growth concerns.

Technical:Possible rebound if price crosses moving averages.

Sentiment:Improving investor confidence in healthcare innovation expected.

News:Anticipated product updates could drive positive momentum.

Strong Buylong term

Strong growth potential in robotic surgery market. ISRG positioned as leader.

Valuation:High P/E justified by long-term growth prospects.

Technical:Long-term trends favor upward price movement.

Sentiment:Strong positive sentiment for healthcare tech leaders.

News:Ongoing innovation and partnerships likely to boost outlook.